After nearly 60 years, Mylan makes way for Viatris
After nearly 60 years as a West Virginia and Pennsylvania pharmaceutical company, Mylan NV has transformed into Viatris (Nasdaq: VTRS), the global drug manufacturer formed with the merger of Mylan and the Upjohn division of Pfizer Inc. (NYSE: PFE)
The merger, announced in late July 2019, took effect Monday. The new company will trade on Nasdaq with the ticker symbol VTRS, and Mylan (Nasdaq: MYL) will no longer trade.
Viatris is headquartered in the United States and will retain its Canonsburg facility…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Paul J. Gough Source Type: news